AUS
NZ
UK
CA
USA
IND
Health
How Are Institutional Investors Adjusting Theiar Positions in CVS Health (NYSE:CVS)?
February 10, 2025 03:04 AM PST| By Team Kalkine MediaHighlights,Institutional investors have increased their positions in CVS Health (NYSE:CVS), reflecting ongoing adjustments in portfolio allocations.,Multiple firms, including Moloney Securities Asset Management LLC and Kingsview Wealth Management LLC...
Is Institutional Interest in Pfizer (NYSE:PFE) Growing?
February 10, 2025 03:04 AM PST| By Team Kalkine MediaHighlights,WCM Investment Management LLC increased its stake in Pfizer,(NYSE:PFE),by 128.7% in the fourth quarter.,Major firms such as Charles Schwab and UBS AM expanded their positions in Pfizer during recent quarters.,Institutional investors now ho...
What Are the Key Developments Surrounding Avantor (NYSE:AVTR)?
February 10, 2025 01:35 AM PST| By Team Kalkine MediaHighlights,Avantor (NYSE:AVTR) reported earnings per share of $0.27 for Q2, surpassing prior estimates.,The company maintained a net margin of 4.54% with a return on equity of 12.24%.,Several financial institutions recently revised their assessments...
Is Haemonetics (NYSE:HAE) Gaining Momentum in the Medical Devices Sector?
February 09, 2025 07:12 PM PST| By Team Kalkine MediaHighlights,Haemonetics,(NYSE:HAE),operates within the medical devices sector, specializing in blood management solutions.,The company reported its latest earnings with a revenue update and operational insights.,Haemonetics maintains a strong presence...
Is Abbott Laboratories (NYSE:ABT) Strengthening Its Position in the Healthcare Sector?
February 09, 2025 01:15 AM PST| By Team Kalkine MediaHighlights,Abbott Laboratories (NYSE:ABT) continues to expand its presence in the healthcare sector through innovative product development.,Recent advancements in medical devices and diagnostics reinforce its leadership in the industry.,Strategic gro...
Is Institutional Interest in GSK plc (NYSE:GSK) Growing?
February 08, 2025 09:06 PM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their holdings in GSK plc (NYSE:GSK), reflecting strategic shifts.,Several firms have recently increased their positions in the pharmaceutical company.,GSK remains a key player in the pharmaceutical se...
Is Premier, Inc. (NASDAQ:PINC) Drawing Enhanced Institutional Interest?
February 08, 2025 02:28 AM PST| By Team Kalkine MediaHighlights,KBC Group NV increased its stake in Premier, Inc. (NASDAQ:PINC) during the recent quarter.,Multiple financial institutions adjusted their positions, reflecting active market participation.,Company leadership executed significant share sale...
Are Institutional Portfolio Changes Reshaping Life Time Group Holdings (NYSE:LTH)?
February 08, 2025 12:52 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC reduced its portfolio significantly in the final quarter.,Institutional investors now own a dominant portion of the company’s stock.,Key company executives adjusted their share positions as part of internal finan...
Will Institutional Adjustments and Executive Share Movements Impact Labcorp (NYSE:LH)?
February 08, 2025 12:52 AM PST| By Team Kalkine MediaHighlights,Significant reduction in position by SG Americas Securities LLC during the final quarter.,New positions established by several institutional investors, with institutions maintaining nearly complete ownership.,Notable adjustments in share p...
Is Centene Corporation (NYSE:CNC) Poised for Further Developments?
February 07, 2025 11:17 PM PST| By Team Kalkine MediaHighlights,Centene Corporation (NYSE:CNC) operates within the healthcare sector, focusing on government-sponsored programs.,The company has experienced adjustments in financial expectations from various research firms.,Centene continues to expand its...
Exploring the Impact of Institutional Changes on Fulgent Genetics (NASDAQ:FLGT)
February 07, 2025 09:40 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC reduced its stake in Fulgent Genetics by a significant amount during the fourth quarter.,A large portion of Fulgent Genetics' stock is held by hedge funds and institutional investors.,Shifting stock ratings have...
How Are Institutional Investments Impacting Summit Therapeutics (NASDAQ:SMMT)
February 07, 2025 09:40 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC reduced its holdings in Summit Therapeutics during the fourth quarter.,The company continues to advance its research efforts with Ivonescimab and innovative antibiotics.,Financial firms issued varied assessments,...
How McKesson (NYSE:MCK) Is Navigating Recent Stock Volatility
February 07, 2025 09:10 AM PST| By Team Kalkine MediaHighlights,McKesson's earnings report fell below expectations, leading to a decline in share price.,The company maintains strong institutional ownership and positive analyst ratings.,A quarterly dividend was announced, reinforcing its commitment to s...
How Are Institutional Investors Adjusting Their Holdings in Teladoc Health (NYSE:TDOC)
February 07, 2025 09:04 AM PST| By Team Kalkine MediaHighlights,Teladoc Health experienced a 307% increase in call options trading volume, reflecting heightened market activity.,Financial firms have adjusted their evaluations, with a consensus price target of $11.97.,Institutional investors have signif...
How Are Institutional Investors Adjusting Their Holdings in Recursion Pharmaceuticals (NASDAQ:RXRX)
February 07, 2025 09:02 AM PST| By Team Kalkine MediaHighlights,Recursion Pharmaceuticals experienced an increase in options trading, with call options surging 51% above the daily average.,Financial firms have provided mixed evaluations, with varied price targets.,Institutional investors remain active,...
How Is Patterson Companies (NASDAQ:PDCO) Maintaining Stability in a Shifting Market
February 07, 2025 09:00 AM PST| By Team Kalkine MediaHighlights,KBC Group NV expanded its stake in Patterson Companies by a significant percentage during the fourth quarter.,A large portion of the company’s stock is held by institutional firms, reflecting strong market engagement.,Recent share transact...
How Is Merck & Co. (NYSE:MRK) Adapting to Industry Challenges
February 07, 2025 08:48 AM PST| By Team Kalkine MediaHighlights,Citigroup revised its price target for Merck & Co., adjusting it from $125 to $115 while maintaining an optimistic stance.,Various financial firms issued mixed ratings, with a general consensus of moderate buy.,Merck announced a strategic...
How Are Institutional Investors Adjusting Their Holdings in Regeneron Pharmaceuticals (NASDAQ:REGN)
February 07, 2025 08:34 AM PST| By Team Kalkine MediaHighlights,Financial firms have revised their evaluations of Regeneron Pharmaceuticals.,The company reported strong earnings growth, surpassing expectations.,Institutional investors have shown dynamic engagement with the stock.,Regeneron Pharmaceutic...
Is Regeneron Pharmaceuticals (NASDAQ:REGN) Strengthening Its Position in the Biopharmaceutical Industry
February 07, 2025 08:22 AM PST| By Team Kalkine MediaHighlights,Financial firms have revised their evaluations of Regeneron Pharmaceuticals.,The company reported strong earnings, surpassing previous estimates.,Institutional investors continue to adjust their holdings in the company.,Regeneron Pharmaceu...
Molina Healthcare (NYSE:MOH) Sees Stock Decline Amid Earnings Miss
February 07, 2025 08:00 AM PST| By Team Kalkine MediaHighlights,Molina Healthcare stock fell sharply after its earnings report.,Earnings per share missed expectations but financials remain stable.,Institutional investors made minor adjustments to their holdings.,Molina Healthcare Inc. a managed healthc...
